Article
Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.
Frontiers in neurology - 1 Jan 2026
Parmova Olesja, Adamova Blanka
Abstract excerpt
Background: The severity of spinal muscular atrophy (SMA) is partially influenced by SMN2 copy number, although this relationship becomes less reliable at higher copy numbers. The implementation of newborn screening has led to increasing identification of presymptomatic infants with five SMN2 copies, a subgroup for which long-term clinical outcomes remain poorly defined. Consequently, treatment decisions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
